HCPLive Network

Improving Outcomes in Pediatric Surgery

A groundbreaking surgical quality improvement program for children has the potential to identify outcomes of surgical care that can be targeted for quality improvement efforts to prevent complications and save lives, according to research published in the Journal of the American College of Surgeons.

A partnership of the American College of Surgeons (ACS) and the American Pediatric Surgical Association, the American College of Surgeons National Surgical Quality Improvement Program-Pediatric (ACS NSQIP Peds) was developed based on a similar project that has been shown to help hospitals prevent between 250-500 complications and save 12-36 lives per hospital each year.

Based on the successes of ACS NSQIP, there has been great interest in a quality improvement program focused on measuring outcomes for pediatric surgery patients. The study demonstrates that the principles of ACS NSQIP can be translated to pediatric cases to help hospitals measure children’s outcomes. Hospitals could then use that data to learn how to prevent complications, save lives and reduce costs.

“As health reform components are implemented over the next several years, we will see a greater focus on measuring patient outcomes and tying reimbursement to quality of care,” said Clifford Y. Ko, MD, FACS, director of the ACS Division of Research and Optimal Patient Care, and one of the study’s authors. “Having robust clinical data in a nationally benchmarked, continuously updated database is an essential element to quality improvement. We now know the tools that have prevented complications and saved lives of adults can also be used for children.”

In the study, outcomes for 7,287 patients who underwent a surgical procedure between October 2008 and December 2009 were collected from four participating hospitals: Yale New Haven Children’s Hospital, New Haven, CT; A.I. DuPont Hospital for Children, Wilmington, DE; The Children’s Hospital, Aurora, CO; and Children’s Hospital of Wisconsin, Milwaukee, WI. Participants collected data for general/thoracic surgery, otolaryngology, orthopedic surgery, urology, neurosurgery and plastic surgery.

The overall mortality rate was 0.3%, and 3.9% of patients experienced a post-operative complication. Infection was the most common complication, with rates varying by specialty and procedure. Variability in the rate of complications indicates that there are opportunities to identify what rates are above and below the hospital’s expected rate, and for hospitals with higher than expected rates of complication to learn from those centers with low rates in order to improve quality of care.

The program is currently in the pilot stage, and future developments will focus on risk-adjusting data to account for the health of the patient prior to the operation, and targeting specific procedures so that hospitals can focus quality improvement efforts on procedures with higher rates of complications. The program is now in phase 2 of development at 29 hospitals around the country.

Source: American College of Surgeons
Further Reading
The US Food and Drug Administration recently announced the approval of the KRONUS Zinc Transporter 8 Autoantibody (ZnT8Ab) ELISA Assay, a new test for type 1 diabetes.
The first two Americans to be treated for the Ebola virus on US soil became the first American patients to be discharged from the hospital where they had been kept in isolation for treatment from the virus.
The United Kingdom’s National Institute for Health and Care Excellence (NICE) is recommending Solvaldi as a cost-effective option to treat some people who have chronic hepatitis C.
Cerdelga (eliglustat) has been approved by the US Food and Drug Administration to treat type 1 Gaucher disease, a rare inherited disorder caused by the body's insufficient production of a key enzyme.
Exposure to secondhand smoke in utero or during infancy impacts the development of allergic disease up to adolescence, according to a study published online Aug. 18 in Pediatrics.
For healthy adults challenged with respiratory syncytial virus, an oral RSV-entry inhibitor, GS-5806, is associated with reduced viral load, according to a study published in the Aug. 21 issue of the New England Journal of Medicine.
More than 40% of women undergo breast reconstruction following mastectomy and most patients are satisfied with the reconstruction decision-making process, according to a study published online Aug. 20 in JAMA Surgery.
More Reading